Geneos Wealth Management’s Rentokil RTO Stock Holding History

Geneos Wealth Management’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.1K	Sell	969 -7,475	-89%	-$188K	﹤0.01%	2125
2026 Q2	$242K	Sell	8,444 -52	-0.6%	-$1.65K	﹤0.01%	926
2026 Q1	$267K	Sell	8,496 -640	-7%	-$20.2K	0.01%	867
2025 Q4	$269K	Buy	9,136 +8,656	+1,803%	+$240K	0.01%	830
2025 Q3	$12.1K	Sell	480 -126	-21%	-$3.07K	﹤0.01%	1897
2025 Q2	$14.5K	Sell	606 -21	-3%	-$487	﹤0.01%	2169
2025 Q1	$14.4K	Sell	627 -67	-10%	-$1.62K	﹤0.01%	2093
2024 Q4	$17.6K	Buy	+694	New	+$17.6K	﹤0.01%	1791

Other funds holding RTO

River Road Asset Management Louisville, Kentucky $8.42B AUM 5.65% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $9.18B AUM 10.37% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Pacifica Capital Investments Leander, Texas $282M AUM 5.46% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Geneos Wealth Management's RTO Position: Q3 2026 in Review

Geneos Wealth Management reduced its Rentokil (RTO) stake by 89% in Q3 2026, selling an estimated $188K and leaving 969 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

Geneos Wealth Management first reported a position in RTO in Q4 2024 and has held it in 8 quarters since. The position peaked at $269K in Q4 2025. 136 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

Geneos Wealth Management held 969 shares of Rentokil worth $19.1K as of Q3 2026.
Geneos Wealth Management sold 7,475 Rentokil shares in Q3 2026, an estimated $188K.
Rentokil made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2125 holding.
Geneos Wealth Management first reported a position in Rentokil in Q4 2024 and has held it in 8 quarters since.
Geneos Wealth Management's Rentokil position peaked at $269K in Q4 2025.
136 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.